The Times of India lauds new efforts in the subcontinent to encourage the growth of its biotech industry [1]. Under new legislation, the country's department of biotechnology is now setting aside 30 percent of its annual budget to fund public/private collaborations on new drug development. A new council has been created to help coordinate efforts between academics and biotech companies and a new regulatory body has been created. India has a shortage of trained regulators, but the Times editorial suggests that the FDA may step in to help train personnel.

- read the editorial [2] in the Times of India

Related Articles:
India emerging as big drug market. Report [3]
China surges past India in drug discovery work. Report [4]
China now leads India in ongoing clinical trials. Report [5]
Bangalore Bio: India's biotech future is bright. Report [6]